
doi: 10.1136/bmj.f6579
pmid: 24201334
Idiopathic pulmonary fibrosis (IPF) is a steadily progressive and ultimately fatal disease of unknown origin. Recent years have seen advances in our understanding of IPF and a number of guidelines have been published. But many questions remain unanswered, particularly surrounding probable versus definite IPF. This Monograph aims to discuss the latest achievements in IPF, and covers key diagnostic issues, staging of the disease, complications and comorbidities, treatment, unmet patient needs and perspectives for the future. This book will be of interest to all clinicians and researchers in this area.
Diagnosis, Differential, Clinical Trials as Topic, Treatment Outcome, Pyridones, Anti-Inflammatory Agents, Non-Steroidal, Practice Guidelines as Topic, Humans, Idiopathic Pulmonary Fibrosis
Diagnosis, Differential, Clinical Trials as Topic, Treatment Outcome, Pyridones, Anti-Inflammatory Agents, Non-Steroidal, Practice Guidelines as Topic, Humans, Idiopathic Pulmonary Fibrosis
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 15 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
